ALPK1 and benign spiradenoma: We next focused on genes identified from our analysis of the discovery cohort (see Methods), revealing ALPK1 p.V1092A mutations in one cylindroma–spiradenoma hybrid, two low-grade spiradenocarcinomas, and one spiradenoma.